Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Apr 24 424B3 Prospectus supplement
- 2 Jan 24 424B5 Prospectus supplement for primary offering
- 13 Nov 23 424B5 Prospectus supplement for primary offering
- 9 Nov 23 424B5 Prospectus supplement for primary offering
- 26 May 23 424B5 Prospectus supplement for primary offering
- 9 Feb 23 424B5 Prospectus supplement for primary offering
- 2 Aug 21 EFFECT Notice of effectiveness
-
23 Jul 21 S-3 Shelf registration
FBIO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Fortress Biotech, Inc.
New York, New York
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2021, relating to the consolidated financial statements appearing in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2020.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP.
Boston, Massachusetts
July 23, 2021